MerLion Pharmaceuticals places shares
Clients MerLion Pharmaceuticals Pte. Ltd.
Jones Day counseled MerLion Pharmaceuticals Pte. Ltd., a pharmaceutical company engaged in the discovery and development of drug candidates for bacterial and fungal resistance levels, in its issuance of Convertible Preferred Stock in a private placement to Aravis Venture, Bio*One Capital Pte. Ltd., Nomura Research and Advisory, Aurelia Private Equity, Brandenburg Capital, Bioveda Capital, Novartis Venture Fund, Mitsubishi Corporation, and 3i Group Investment LP.